BRISTOL-MYERS SQUIBB COMPANY

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AVENUE SOLUTIONS	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	2
SENATE	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	4
Medicare/Medicaid	Medicare/Medicaid	4

Bills Explicitly Cited (4)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA); Issues related to Most Favored Nation (MFN)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4299

S. 3019119th Congress

No Big Blockbuster Bailouts Act

2026 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA); Issues related to Most Favored Nation (MFN)

Client expense: — · Firm income: $60,000

Matched citations: S. 3019

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · second_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4299

S. 3019119th Congress

No Big Blockbuster Bailouts Act

2026 · second_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)

Client expense: — · Firm income: $60,000

Matched citations: S. 3019

Source: Senate LDA

BRISTOL-MYERS SQUIBB COMPANY — Lobbying Disclosure | Poliscope